# Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

Study · id `cardio:ct-nct07122167` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07122167](<https://clinicaltrials.gov/study/NCT07122167>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07122167

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 153 participants.

## Technical summary

Registry record NCT07122167. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-02 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 153 participants (planned count; ClinicalTrials.gov record NCT07122167, source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)
- Started: 2025-06-02 (actual) (ClinicalTrials.gov record NCT07122167, source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07122167, source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)
- Completion: 2027-02-01 (anticipated) (ClinicalTrials.gov record NCT07122167, source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)
- Countries: Poland (ClinicalTrials.gov record NCT07122167, source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07122167-2025-09-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
- Condition: Peripheral Arterial Disease
- Intervention (Device): Peripheral Drug-eluting Stent System
- Lead sponsor: MDCECRO LLC
- Lead sponsor class: NETWORK
- Collaborator: Zylox-Tonbridge Medical Technology Co., Ltd.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: a1581360d5604c6d127bb6ecb5ad85f28e2810863f38f296440643a84c4dfcde
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
